Page 14:
The ability of the Company and the Group to continue as a going concern and fund the path to profitability is dependent upon securing additional funds in the coming months from amongst a range of sources / opportunities including new partnerships and alliances for ADAPT and/or raising additional capital through new equity and debt. The Directors believe that the Company and Group has the ability to raise equity and debt finance.
It bloody better be because of a new partnership or alliance as opposed to another rubbish CR
- Forums
- ASX - By Stock
- AVR
- Ann: Appendix 4D and Half Yearly Financial Report
Ann: Appendix 4D and Half Yearly Financial Report, page-3
-
- There are more pages in this discussion • 240 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M |
Open | High | Low | Value | Volume |
$9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 298 | $9.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.85 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 298 | 9.010 |
1 | 1000 | 9.000 |
1 | 200 | 8.700 |
1 | 200 | 8.500 |
2 | 200 | 8.000 |
Price($) | Vol. | No. |
---|---|---|
9.850 | 1000 | 1 |
9.910 | 231 | 2 |
10.000 | 10250 | 2 |
10.200 | 545 | 1 |
10.500 | 10000 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online